Does DENOSUMAB Cause Mobility decreased? 1,203 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 1,203 reports of Mobility decreased have been filed in association with DENOSUMAB (Bilprevda). This represents 0.8% of all adverse event reports for DENOSUMAB.
1,203
Reports of Mobility decreased with DENOSUMAB
0.8%
of all DENOSUMAB reports
24
Deaths
180
Hospitalizations
How Dangerous Is Mobility decreased From DENOSUMAB?
Of the 1,203 reports, 24 (2.0%) resulted in death, 180 (15.0%) required hospitalization, and 7 (0.6%) were considered life-threatening.
Is Mobility decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 1,203 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Mobility decreased?
ADALIMUMAB (8,829)
ETANERCEPT (8,321)
METHOTREXATE (5,936)
ABATACEPT (4,519)
TOCILIZUMAB (4,403)
LEFLUNOMIDE (4,354)
HYDROXYCHLOROQUINE (4,105)
RITUXIMAB (4,067)
INFLIXIMAB (3,784)
TOFACITINIB (3,734)
Which DENOSUMAB Alternatives Have Lower Mobility decreased Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE